ARTICLE | Company News
Medinet, TC Biopharm deal
March 17, 2014 7:00 AM UTC
TC Biopharm acquired an exclusive, European license to Medinet's cell processing technology. TC Biopharm will use the technology in developing an autologous cancer immunotherapy that involves isolatio...